Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes W van Isselt

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
Re: does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?Marnix G E H Lam, Johannes W van Isselt
Hellenic Journal of Nuclear Medicine|April 23, 2010
The radioiodine turnover rate as a determinant of radioiodine treatment outcome in Graves' diseaseJohannes W van Isselt, Henny S Broekhuizen-de Gast
Anti-Cancer Agents in Medicinal Chemistry|July 17, 2007
Use of radiopharmaceuticals for diagnosis, treatment, and follow-up of differentiated thyroid carcinomaFrederik A Verburg, Bart de Keizer, Johannes W van Isselt
Hellenic Journal of Nuclear Medicine|April 21, 2005
Suspected thyroid stunning after radioiodine-131 scanning in a patient with a diffuse goiterJohannes W van Isselt, P Christine Oldenburg-Ligtenberg, Peter P van Rijk
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2007
Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?Johannes W van Isselt, John M H de Klerk, Cornelis J M Lips
Thyroid : Official Journal of the American Thyroid Association|February 27, 2008
I-131 accumulation in a benign cystic mesothelioma in a patient with follicular thyroid cancerBart de Keizer, Georgios Arsos, Jan W Smit, et al.
European Journal of Endocrinology|June 24, 2008
The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategiesRobbert B T Verkooijen, Frederik A Verburg, Johannes W van Isselt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2003
Comparison of methods for thyroid volume estimation in patients with Graves' diseaseJohannes W van Isselt, John M H de Klerk, Peter P van Rijk, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 22, 2010
No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancerFrederik Anton Verburg, Marcel P M Stokkel, Christian Düren, et al.
World Journal of Surgery|October 24, 2007
Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablationFrederik A Verburg, Bart de Keizer, Marnix G E H Lam, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
Re: does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?Marnix G E H Lam, Johannes W van Isselt
Hellenic Journal of Nuclear Medicine|April 23, 2010
The radioiodine turnover rate as a determinant of radioiodine treatment outcome in Graves' diseaseJohannes W van Isselt, Henny S Broekhuizen-de Gast
Anti-Cancer Agents in Medicinal Chemistry|July 17, 2007
Use of radiopharmaceuticals for diagnosis, treatment, and follow-up of differentiated thyroid carcinomaFrederik A Verburg, Bart de Keizer, Johannes W van Isselt
Hellenic Journal of Nuclear Medicine|April 21, 2005
Suspected thyroid stunning after radioiodine-131 scanning in a patient with a diffuse goiterJohannes W van Isselt, P Christine Oldenburg-Ligtenberg, Peter P van Rijk
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2007
Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?Johannes W van Isselt, John M H de Klerk, Cornelis J M Lips
Thyroid : Official Journal of the American Thyroid Association|February 27, 2008
I-131 accumulation in a benign cystic mesothelioma in a patient with follicular thyroid cancerBart de Keizer, Georgios Arsos, Jan W Smit, et al.
European Journal of Endocrinology|June 24, 2008
The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategiesRobbert B T Verkooijen, Frederik A Verburg, Johannes W van Isselt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2003
Comparison of methods for thyroid volume estimation in patients with Graves' diseaseJohannes W van Isselt, John M H de Klerk, Peter P van Rijk, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 22, 2010
No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancerFrederik Anton Verburg, Marcel P M Stokkel, Christian Düren, et al.
World Journal of Surgery|October 24, 2007
Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablationFrederik A Verburg, Bart de Keizer, Marnix G E H Lam, et al.
Pageof 1